Our History

Martindale Pharma has been in business for over two centuries and our history can be traced back to 1787.

James Macarthy

James Macarthy founded a retail pharmacy in Romford which later became Macarthys Ltd in 1920

William Martindale

William Martindale acquired a pharmacy from Hopkins & Williams located in New Cavendish Street, London

Savory & Moore

W.Martindale was acquired by Savory & Moore Ltd

Romford Laboratories

Romford Laboratories Ltd established

Macarthys Ltd

Savory & Moore Ltd was acquired by Macarthys Ltd

Martindale Pharmaceuticals

Martindale Pharmaceuticals (Martindale) launched as trading styled for Macarthys Laboratories Ltd

Lloyds Chemists

Martindale’s parent company, Macarthy plc acquired by Lloyds Chemists plc

Daniels Pharmaceutical

Martindale acquires Daniels Pharmaceutical Ltd, a manufacturer of ophthalmic products

Penn Pharmaceuticals

Martindale acquires the ‘Specials’ business of Penn Pharmaceuticals

Aurum Pharmaceuticals

Acquisition of Aurum Pharmaceuticals, West Sussex


Acquisition of specials business from AAH

Intercare Group

Acquired by the Intercare Group Plc

Cardinal Health

Acquisition by Cardinal Health

AAC Capital

Management buyout supported by AAC Capital

Proveblue and Aurum Range

Launch of Proveblue and revamped Aurum Range of pre-filled syringes

Joins Fastest Growing Companies

Martindale joins the Sunday Times Deloitte Buyout Track 100 Fastest Growing Companies

Major Product Launches

Launch of Tapclob, Noyada and Prenoxad Injection

Re-locates Headquarters

Martindale re-locates headquarters and commercial operations to Glory Park, Wooburn Green, Buckinghamshire to support ongoing growth and expansion. Manufacturing remains in Romford, Essex with significant investment started to increase capacity and efficiency


Martindale Pharma acquires rights to Teglutik from Italfarmaco


Michael Harris appointed CEO

New Distributors

Appointment of new distributors in Asia Pacific and Scandinavia

New Romford Facility

Opening of new sterile ampoule manufacturing area in Romford facility, increasing capacity to 70 million ampoules per year

Espranor Regulatory Approval

Espranor, a novel product for opioid addiction developed by Martindale Pharma receives first European regulatory approvals, including the UK

Unimedic AB Rights

Martindale Pharma acquires rights to new Emergency Care product from Unimedic AB

Saudi Arabia Expansion

First regulatory approvals for Martindale Pharma products in Saudi Arabia and signing of a new long-term distribution agreement with established partner El Seif

Teglutik Launch

Launch of Teglutik